官方服务：
资源简介：
This is a dataset of IGH repertoires of the LUAD patients from TCGA.
应用场景：
创建时间：
2019-05-24
相关数据集
TCR ?-chain repertoire characterization of regulatory and conventional T cells in peripheral blood from breast cancer patients and healthy individuals.
Identification of tumor-specific effects on peripheral TCR? repertoire formation in humans, investigation of the clonal origin of regulatory T cells in breast cancer patients and impact analysis of th
NIAID Data Ecosystem40
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression (tumor). Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression (tumor)
Immune escape is a prerequisite of tumor growth. We previously described a decline in intratumor activated GZMB+CD8+ T cells and T cell receptor (TCR) clonotype diversity in invasive compared to in si
NIAID Data Ecosystem20
Characterization of tumor-infiltrating T cells by TCR-Ã repertoire analyses
Local administration of IFN-a-producing proliferating myeloid cells (IFN-a-iPSC-pMCs) inhibited the tumor growth not only at the treatment site but also at the distant site (left). T cell receptor (TC
NIAID Data Ecosystem10
TCR repertoire and clinical data from NSCLC cohort
Briefly describe study and files
DataCite Commons2025-12-31 更新20
Treatment with obinutuzumab and venetoclax reshapes the TRB repertoire of CLL patients. Treatment with obinutuzumab and venetoclax reshapes the TRB repertoire of CLL patients
Anti-leukemic treatment in chronic lymphocytic leukemia (CLL) impacts autologous T cells through various direct and indirect mechanisms. However, how first-line treatment with venetoclax and obinutuzu
NIAID Data Ecosystem10
